1 / 7

CANCER DE PANCREAS

El American Joint Committee on C?ncer (AJCC ) TNM. TX: El Tumor Primario No puede Evaluarse T0: No hay Evidencia de Tumor Primario Tis: Carcinoma in situ T1: Tumor Limitado al P?ncreas de 2 cm. o Menos T2: Tumor Limitado al P?ncreas de M?s de 2 cm.. TNM. T3: El Tumor Penetra Directamente en el Duodeno, Conducto Biliar o Tejido Peri pancre?tico. T4: El Tumor Penetra Directamente en el Est?mago, Bazo, Colon o los Vasos Grandes Adyacentes..

rozalia
Download Presentation

CANCER DE PANCREAS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. CANCER DE PANCREAS CATEDRA I CIRUGIA MATERIA ONCOLOGIA PROF. DR. JORGE RAUL ZIMERMAN JEFE DEPARTAMENTO ONCOLOGIA HOSPITAL DR JOSE RAMON VIDAL CORRIENTES ARGENTINA

    2. El American Joint Committee on Cáncer (AJCC ) TNM TX: El Tumor Primario No puede Evaluarse T0: No hay Evidencia de Tumor Primario Tis: Carcinoma in situ T1: Tumor Limitado al Páncreas de 2 cm. o Menos T2: Tumor Limitado al Páncreas de Más de 2 cm.

    3. TNM T3: El Tumor Penetra Directamente en el Duodeno, Conducto Biliar o Tejido Peri pancreático. T4: El Tumor Penetra Directamente en el Estómago, Bazo, Colon o los Vasos Grandes Adyacentes.

    4. TNM NX: Los Ganglios Linfáticos Regionales No pueden Evaluarse N0: No hay Metástasis a los Ganglios Linfáticos Regionales N1: Existe Metástasis a los Ganglios Linfáticos Regionales

    5. TNM MX: La Metástasis Distante No puede Evaluarse M0: No Hay Metástasis Distante M1: Existe Metástasis Distante

    6. ESTADIOS Etapa 0 Tis, N0, M0 Etapa I T1, NO, MO T2, N0, M0 Etapa II T3, N0, M0

    7. ESTADIOS Etapa III T1, N1, M0 T2, N1, M0 T3, N1, M0 Etapa IVA T4, Cualquier N, M0 Etapa IVB Cualquier T, Cualquier N, M1

    8. BIBLIOGRAFIA Moertel CG, Frytak S, Hahn RG, et al.: Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. Cancer 48(8): 1705-1710, 1981. Whittington R, Solin L, Mohiuddin M, et al.: Multimodality therapy of localized unresectable pancreatic adenocarcinoma. Cancer 54(9): 1991-1998, 1984. Moertel CG, Childs DS, Reitemeier RJ, et al.: Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 2(7626): 865-867, 1969. Tepper JE, Noyes D, Krall JM, et al.: Intraoperative radiation therapy of pancreatic carcinoma: a report of RTOG-8505. International Journal of Radiation Oncology, Biology, Physics 21(5): 1145-1149, 1991. Kalser MH, Ellenberg SS: Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Archives of Surgery 120(8): 899-903, 1985. Polati E, Finco G, Gottin L, et al.: Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. British Journal of Surgery 85(2): 199-201, 1998. Gastrointestinal Tumor Study Group: Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59(12): 2006-2010, 1987. van den Bosch RP, van der Schelling GP, Klinkenbijl JH, et al.: Guidelines for the application of surgery and endoprostheses in the palliation of obstructive jaundice in advanced cancer of the pancreas. Annals of Surgery 219(1): 18-24, 1994. Baron TH: Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. New

More Related